Friday, March 4, 2022

< + > Antibody-Activated Endothelial Cells Increase the Risk of Blood Clots with Covid-19

Antiphospholipid antibodies activity may help explain hypercoagulation associated with late stages of Covid-19 and long-haul disease. Blood samples from nearly 250 individuals hospitalized for Covid-19 found that these “rouge” antibodies activate endothelial cells, risking widespread blood clots.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Bonus Features – July 5, 2026 – 58% of dermatology practices see patients daily with AI-generated diagnoses, 94% of CIOs say AI delays would put their orgs at a competitive disadvantage, plus 27 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...